Correspondence 0001575872-25-000143 from Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc.
Date: Feb. 10, 2025 · CIK: 0001941029 · Accession: 0001575872-25-000143
AI Filing Summary & Sentiment
File numbers found in text: 333-272110
Letter
Craft Capital Management LLC
377 Oak Street, Lower Concourse
Garden City, NY 11530
February 10, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attn: Al Pavot, Robert Augustin, and Margaret Schwartz
Re: Advanced Biomed Inc. (CIK No. 0001941029)
Registration Statement on Form S-1, as amended (File No. 333-272110)
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the other underwriters, hereby join in the request of Advanced Biomed Inc. that the effective date of the above-referenced registration statement be accelerated so as to permit it to become effective at 4:30 p.m., Eastern Time, on February 11, 2025 or as soon thereafter as practicable.
Pursuant to 460 under the Act, we wish to advise you that the underwriters will distribute as many copies of the preliminary prospectus dated February 7, 2025 to underwriters, dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.
The undersigned advises that it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Craft Capital Management LLC
Show Raw Text
CORRESP
1
filename1.htm
Craft Capital Management LLC
377 Oak Street, Lower Concourse
Garden City, NY 11530
February 10, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Industrial Applications and Services
100 F Street, N.E.
Washington, D.C. 20549
Attn: Al Pavot, Robert Augustin, and Margaret Schwartz
Re: Advanced Biomed Inc. (CIK No. 0001941029)
Registration Statement on Form S-1, as amended (File No. 333-272110)
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), the undersigned, for itself and the
other underwriters, hereby join in the request of Advanced Biomed Inc. that the effective date of the above-referenced registration statement
be accelerated so as to permit it to become effective at 4:30 p.m., Eastern Time, on February 11, 2025 or as soon thereafter as practicable.
Pursuant to 460 under the Act,
we wish to advise you that the underwriters will distribute as many copies of the preliminary prospectus dated February 7, 2025 to underwriters,
dealers, institutions and others as appears to be reasonable to secure adequate distribution of such preliminary prospectus.
The undersigned advises that
it has complied and will continue to comply with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Very truly yours,
Craft Capital Management LLC
By:
/s/ Stephen Kiront
Name:
Stephen Kiront
Title:
Chief Operating Officer